Univest
Univest
  • Markets

Privi Speciality Chemicals Q1 Results FY27: Net Profit at Rs 82 Cr for June 2026 Quarter

  • July 31, 2026
  • Posted by: Ankit Jaiswal
  • Category: Mutual Funds
No Comments
Privi Speciality Chemicals Q1 Results FY27: Net Profit at Rs 82 Cr for June 2026 Quarter

Privi Speciality Chemicals Q1 results FY27: Revenue Rs 666 Cr. Net profit Rs 82 Cr. Consolidated basis. Stock at Rs 3,573 (-3.62%) on 30 July 2026.

Table of Contents

Toggle
  • Key Takeaways
  • Privi Speciality Chemicals Q1 Results FY27: Key Numbers at a Glance
  • Privi Speciality Chemicals Q1 Results FY27: What Drove Revenue
  • Privi Speciality Chemicals Q1 Results FY27: Profitability Breakdown
  • Stock Price Reaction to the Privi Speciality Chemicals Q1 Results FY27
  • What the Privi Speciality Chemicals Q1 Results FY27 Mean for Investors
  • Business Context Behind the Privi Speciality Chemicals Q1 Results FY27
  • Key Things to Watch After the Privi Speciality Chemicals Q1 Results FY27
  • Conclusion
  • FAQs on Privi Speciality Chemicals Q1 Results FY27
    • What was Privi Speciality Chemicals’s revenue in Q1 results FY27?
    • Did Privi Speciality Chemicals make a profit or loss in Q1 FY27?
    • What was Privi Speciality Chemicals’s gross profit in Q1 FY27?
    • When were the Privi Speciality Chemicals Q1 results FY27 announced?
    • Did Privi Speciality Chemicals shares go up or down after the Q1 results FY27?
    • Were the Privi Speciality Chemicals Q1 results FY27 consolidated or standalone?
    • What should investors watch after Privi Speciality Chemicals’s Q1 results FY27?
    • Are the Privi Speciality Chemicals Q1 results FY27 a buy signal?

Key Takeaways

  • Privi Speciality Chemicals’s revenue for the June 2026 quarter came in at Rs 666 Cr, rose 19.22% year on year from Rs 558 Cr.
  • Privi Speciality Chemicals came in at a consolidated net profit of Rs 82 Cr, up 43.94% from Rs 57 Cr in Q1 FY26.
  • Gross profit was reported at Rs 114 Cr for the quarter.
  • The stock traded at Rs 3,573 on 30 July 2026, down 3.62% during the session.

If you are searching for Privi Speciality Chemicals Q1 results FY27, here is the direct answer: Privi Speciality Chemicals reported consolidated revenue of Rs 666 Cr and a net profit of Rs 82 Cr for the quarter ended 30 June 2026, rose 19.22% year on year from Rs 558 Cr. The rest of this article expands on that answer with the full revenue and profit breakdown, what changed compared with Q1 FY26, how the stock reacted, and what to watch next, so you do not need to piece it together from multiple sources.

Prepared by Ankit Jaiswal, Senior Research Analyst at Univest, this review of the Privi Speciality Chemicals Q1 results FY27 is based on figures disclosed in the company’s exchange filing for the June 2026 quarter.

Click Here – Get Free Investment Predictions

Privi Speciality Chemicals Q1 Results FY27: Key Numbers at a Glance

Metric Q1 FY27 Q1 FY26 YoY Change
Revenue Rs 666 Cr Rs 558 Cr 19.22%
Gross Profit Rs 114 Cr Rs 95 Cr 19.88%
Net Profit Rs 82 Cr Rs 57 Cr 43.94%

All figures in the Privi Speciality Chemicals Q1 results FY27 table above are on a consolidated basis for the quarter ended 30 June 2026, compared with Q1 FY26. This is the core data set behind the Privi Speciality Chemicals Q1 results FY27 search.

Privi Speciality Chemicals Q1 Results FY27: What Drove Revenue

Revenue for Privi Speciality Chemicals in Q1 FY27 rose 19.22% from Rs 558 Cr to Rs 666 Cr, against Rs 558 Cr in Q1 FY26. Anyone comparing Privi Speciality Chemicals against its own past performance should treat this as the base number: a company in the aroma chemicals space, this pace of growth reflects demand and pricing trends specific to that segment during the June 2026 quarter.

Privi Speciality Chemicals Q1 Results FY27: Profitability Breakdown

Privi Speciality Chemicals came in at a consolidated net profit of Rs 82 Cr, up 43.94% from Rs 57 Cr in Q1 FY26 in Q1 FY27. Gross profit for the quarter was Rs 114 Cr, a change of 19.88% from Rs 95 Cr in Q1 FY26.

The broadly consistent movement between gross profit and net profit in the Privi Speciality Chemicals Q1 results FY27 suggests the quarter’s profit performance is being driven mainly by core operations rather than one-off or below-the-line items.

Stock Price Reaction to the Privi Speciality Chemicals Q1 Results FY27

Privi Speciality Chemicals shares traded at Rs 3,573 on 30 July 2026, down 3.62% during the session. If your search intent is specifically about the stock reaction rather than the raw numbers, this is the figure that answers it: the market’s verdict weighed the revenue and profit results together, alongside broader market conditions on the day.

Talk to a SEBI Registered Investment Adviser Before You Invest

What the Privi Speciality Chemicals Q1 Results FY27 Mean for Investors

The Privi Speciality Chemicals Q1 results FY27 give investors three concrete data points: a revenue base of Rs 666 Cr, a net profit of Rs 82 Cr, and a year-on-year growth trajectory that either confirms or challenges the investment thesis for the stock. None of these numbers should be read in isolation from the detailed exchange filing, segment disclosures and management commentary that typically accompany results.

Comparing this quarter with peers in the aroma chemicals space is also useful context. A company can post strong absolute growth and still lag its peer set, or post modest growth that is nonetheless best-in-class for its sector, so relative positioning matters as much as the standalone numbers in the Privi Speciality Chemicals Q1 results FY27. Investors who track a basket of names in the same industry will typically get a clearer read on whether this quarter reflects a company-specific story or a broader sector trend.

Business Context Behind the Privi Speciality Chemicals Q1 Results FY27

Privi Speciality Chemicals operates in the aroma chemicals space, where demand cycles, input costs and competitive intensity all shape quarterly performance. The Privi Speciality Chemicals Q1 results FY27 should be read against these sector-level dynamics rather than as a standalone number, since the same growth rate can carry very different implications depending on the underlying industry conditions.

Quarterly results are unaudited and subject to limited review, so any restatements or exceptional items disclosed in the notes to the Privi Speciality Chemicals Q1 results FY27 can shift how the reported profit should be interpreted. Reading the full exchange filing alongside this summary remains the most reliable way to form a complete view, particularly for line items such as other income, exceptional items and tax adjustments that do not always show up in a headline summary.

Key Things to Watch After the Privi Speciality Chemicals Q1 Results FY27

  • Sequential trend: Whether the momentum in the Privi Speciality Chemicals Q1 results FY27 carries into the September 2026 quarter or proves to be a one-off.
  • Management commentary: Guidance on demand, margins and capital allocation for the rest of FY27.
  • Sector conditions: Developments in the aroma chemicals space that could influence input costs, pricing power or competitive intensity.
  • Corporate actions: Any dividend, capex or strategic announcements accompanying the results that signal management’s confidence in the outlook.
  • Balance sheet health: Debt levels, working capital trends and cash flow generation, which together determine how much flexibility Privi Speciality Chemicals has to fund future growth.

Download the Univest iOS App or Univest Android App to track quarterly results, live prices and research updates in one place.

Conclusion

The Privi Speciality Chemicals Q1 results FY27 show consolidated revenue of Rs 666 Cr and a net profit of Rs 82 Cr for the quarter ended 30 June 2026. The quarter’s profit delivery keeps the near-term earnings narrative broadly intact. As Ankit Jaiswal notes, investors should track the next few quarterly prints and management commentary before drawing firm conclusions, and consult a SEBI registered investment adviser before acting on these results.

Disclaimer: This article is for educational and informational purposes only and should not be considered investment advice. Revenue, gross profit and net profit figures are sourced from the company’s exchange filings for the quarter ended 30 June 2026. Stock market investments are subject to risks. Please consult a SEBI registered investment adviser before making any investment decision. Univest Research Analyst SEBI Registration No. INH000013776.

FAQs on Privi Speciality Chemicals Q1 Results FY27

What was Privi Speciality Chemicals’s revenue in Q1 results FY27?

Ans. Privi Speciality Chemicals’s revenue in Q1 results FY27 was Rs 666 Cr, rose 19.22% year on year from Rs 558 Cr.

Did Privi Speciality Chemicals make a profit or loss in Q1 FY27?

Ans. Privi Speciality Chemicals reported a net profit of Rs 82 Cr in Q1 results FY27 on a consolidated basis for the quarter ended 30 June 2026.

What was Privi Speciality Chemicals’s gross profit in Q1 FY27?

Ans. Privi Speciality Chemicals’s gross profit in Q1 results FY27 was Rs 114 Cr, against Rs 95 Cr in Q1 FY26.

When were the Privi Speciality Chemicals Q1 results FY27 announced?

Ans. The Privi Speciality Chemicals Q1 results FY27 were announced on 30 July 2026, covering the quarter ended 30 June 2026.

Did Privi Speciality Chemicals shares go up or down after the Q1 results FY27?

Ans. Privi Speciality Chemicals shares traded at Rs 3,573 on 30 July 2026, down 3.62% following the Q1 results FY27.

Were the Privi Speciality Chemicals Q1 results FY27 consolidated or standalone?

Ans. The Privi Speciality Chemicals Q1 results FY27 are on a consolidated basis, as reported in the company’s exchange filing for the June 2026 quarter.

What should investors watch after Privi Speciality Chemicals’s Q1 results FY27?

Ans. Investors should watch the sequential trend into the September quarter, management commentary, sector-level conditions in the aroma chemicals space, and any corporate action announcements.

Are the Privi Speciality Chemicals Q1 results FY27 a buy signal?

Ans. Quarterly results are a data point, not a recommendation. Investors should assess valuations, earnings quality and their own risk profile, and consult a SEBI registered investment adviser before investing.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply